A response by Strauss et al. to “a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia”

William E. Strauss, N. Franklin Adkinson, Iain C. Macdougall, Michael Auerbach, Robert F. Kaper, Glenn M. Chertow, Julie S. Krop

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)E232-E233
JournalAmerican journal of hematology
Volume93
Issue number9
DOIs
StatePublished - Sep 2018

ASJC Scopus subject areas

  • Hematology

Cite this